Expanded Access: Past, Present and Future Improvements
Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Expanded access is a program that provides patients with investigational medicinal products (IMP) for treatment purposes. These patients are often excluded from clinical trials but could still benefit from access to the drugs, biologics or medical devices being tested. While, in concept, expanded access represents a way to help more patients receive new and developing treatments, in reality, the process is complex and often misunderstood.
Related Education Resources.
All ResourcesRecent Developments in the Global Regulatory Landscape
Topic: Regulatory
Webinar
Free
Guy Disney - European Knowledge Forum Keynote Speaker 2022
Topic: Conference
Video
Members
2023 EKF Workshop - Understanding Blockchain and Artificial Intelligence in the Clinical Supply Chain
Topics: EKF - 2023, Supply Chain, Technology
Presentation
Members